Anti-proliferattve effects of unmodified antisense oligodeoxynucleotides targeted against c-raf mRNA: Use of poly (lysine/serine) copolymers or cationic lipopolyamines

Clinical and Experimental Pharmacology and Physiology

Volumn 25, Issue 9, 1998, Pages 702-705

  Aoki, Y ^a   Kawa, S ^a   Karasawa, Y ^a   Horiuchi, A ^a   Kiyosawa, K ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anisense DNA; c raf; Pancreatic cancer; Synthetic carriers

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; COPOLYMER; DRUG CARRIER; MESSENGER RNA; ANTISENSE OLIGONUCLEOTIDE; CATION; DIOCTADECYLAMIDOGLYCYLSPERMINE; DRUG DERIVATIVE; GLYCINE; MACROGOL DERIVATIVE; NUCLEOTIDE; PEPTIDE; PHARMACEUTICAL VEHICLES AND ADDITIVES; POLYAMINE; POLYLYSINE; POLYSERINE; RAF PROTEIN; SPERMINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; ONCOGENE C RAF; PANCREAS CANCER; CELL CULTURE; CELL DIVISION; GENETICS; METABOLISM; PANCREAS TUMOR; PATHOLOGY;

CATIONS; CELL DIVISION; DRUG CARRIERS; GLYCINE; HUMANS; OLIGONUCLEOTIDES, ANTISENSE; PANCREATIC NEOPLASMS; PEPTIDES; PHARMACEUTIC AIDS; POLYAMINES; POLYETHYLENE GLYCOLS; POLYLYSINE; PROTO-ONCOGENE PROTEINS C-RAF; RNA, MESSENGER; SPERMINE; THIONUCLEOTIDES; TUMOR CELLS, CULTURED;

EID: 0031595190     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1998.tb02279.x     Document Type: Article

References (19)

1. Gura T. Antisense has growing pains. Science 1995; 270: 575-7.
2. Stein CA. Does antisense exist? It may, but only under very special circumstances. Nature Med. 1995; 1: 1119-21.
3. Monia BP, Johnston JF, Geiger T, Muller M, Fabbro D. Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase. Nature Med. 1996; 2: 668-75.
4. Lemaitre M, Bayard B, Lebleu B. Specific antiviral activity of a poly (L-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site. Proc. Natl Acad. Sci. USA 1987; 84: 648-52.
5. Saldeen J, Curiel DT, Eizirik DL et al. Efficient gene transfer to dispersed human pancreatic islet cells in vitro using adenovirus-polylysine/DNA complexes or polycationic liposomes. Diabetes 1996; 45: 1197-203.
6. Behr J-P, Demeneix B, Loeffler J-P, Peres-Mutul J. Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA. Proc. Natl Acad. Sci. USA 1989; 86: 6982-6.
7. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing. Cancer Res. 1987; 47: 936-42.
8. Bergmann U, Funatomi H, Yokoyama M, Beger HG, Korc M. Insulin-like growth factor I overexpression in human pancreatic cancer: Evidence for autocrine and paracrine roles. Cancer Res. 1995; 55: 2007-11.
9. Bonner TI, Oppermann H, Seeburg PH et al. The complete coding sequence of the human raf oncogene and the corresponding structure of the c-raf-1 gene. Nucleic Acids Res. 1986; 14: 1009-15.
10. Hahn SA, Schutte M, Shamsul Hoque ATM et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996; 271: 350-3.
11. Nishida E, Gotoh Y. The MAP kinase cascade is essential for diverse signal transduction pathway. Trends Biol. Sci. 1993; 18: 128-31.
12. Vojtek AB, Hollenberg SM, Cooper JA. Mammalian ras interacts directly with the serine/threonine kinase raf. Cell 1993; 74: 205-14.
13. Warshaw AL, Fernandez-del Castillo C. Pancreatic carcinoma. N. Engl. J. Med. 1992; 326: 455-65.
14. Krontiris TG. Oncogenes. N. Engl. J. Med. 1995; 333: 303-6.
15. Jayaraman L, Prives C. Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus. Cell 1995; 81: 1021-9.
16. Dean NM, McKay R. Inhibition of protein kinase C-alpha expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides. Proc. Natl Acad. Sci. USA 1994; 91: 11 762-6.
17. Neurath MF, Pettersson S, Meyer zum Büschenfelde K-H, Strober W. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κB abrogates established experimental colitis in mice. Nature Med. 1996; 2: 998-1004.
18. Aoki K, Yoshida T, Matsumoto N et al. Gene therapy for peritoneal dissemination of pancreatic cancer by liposome-mediated transfer of Herpes simplex virus thymidine kinase gene. Hum. Gene Ther. 1997; 8: 1105-13.
19. Chiang MY, Chen H, Zounes MA, Freier SM, Lima WF, Bennett CF. Antisense oligonucleotides inhibit intercellular adhesion molecule-1 expression by two distinct mechanisms. J. Biol. Chem. 1991; 266: 18 162-71.